Requires Medicaid coverage for ovulation enhancing drugs and medical services related to administering such drugs for certain beneficiaries experiencing infertility.

This bill would require New Jersey's Medicaid program to cover ovulation-enhancing drugs and the medical services needed to administer them for Medicaid beneficiaries experiencing infertility. It amends the state's Medicaid law to add these specific services as a covered benefit, which are not currently included in standard Medicaid coverage. The policy change would directly affect low-income New Jersey residents seeking fertility treatments through Medicaid. The bill was introduced in the Senate on January 9, 2024, and referred to the Health Committee.